Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

626
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racialized Heteroscedasticity in Neuroimaging Features, Behavior Measures, and Neuroimaging-Based Predictive Models.

Research square·2026
Same author

The 2026 global roadmap for textile-integrated wearable technologies in health.

Physiological measurement·2026
Same author

Shotgun metagenomic profiling reveals ecological and functional alterations of the oral microbiome in craniosynostosis.

Journal of oral microbiology·2026
Same author

GatorSC: multi-scale cell and gene graphs with mixture-of-experts fusion for single-cell transcriptomics.

Briefings in bioinformatics·2026
Same author

Interpretable graph-based models on multimodal biomedical data integration: a technical review and benchmarking.

Nature communications·2026
Same author

From tooth to gut: Proteomic evidence of systemic dysregulation in fluorosis.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: Aug 23, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

A Cascaded Mutliresolution Ensemble Deep Learning Framework for Large Scale Alzheimer's Disease Detection Using Brain

Imran Razzak, Saeeda Naz, Hamid Alinejad-Rokny

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |November 2, 2022
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel deep learning framework for diagnosing Alzheimer's disease (AD) using brain MRIs. The proposed system, PartialNet, demonstrates superior accuracy in detecting AD, outperforming existing methods.

    More Related Videos

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
    12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    40.3K
    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
    09:06

    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

    Published on: June 9, 2018

    12.2K

    Related Experiment Videos

    Last Updated: Aug 23, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.2K
    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
    12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    40.3K
    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
    09:06

    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

    Published on: June 9, 2018

    12.2K

    Area of Science:

    • Neurology
    • Artificial Intelligence
    • Medical Imaging

    Background:

    • Alzheimer's disease (AD) is a progressive dementia impacting cognitive functions.
    • Current AD diagnosis lacks a definitive single test, often relying on imaging like MRI.
    • Identifying reliable diagnostic tools for AD is crucial for early intervention.

    Purpose of the Study:

    • To develop an advanced deep learning framework for accurate Alzheimer's disease diagnosis.
    • To enhance predictive performance in detecting Alzheimer's disease using brain Magnetic Resonance Imaging (MRI).

    Main Methods:

    • An integrative, multi-resolutional ensemble deep learning framework utilizing a hierarchical PartialNet design.
    • The framework was evaluated on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset comprising 379 subjects.
    • Comparison against established deep learning models like ResNet and DenseNet variants.

    Main Results:

    • The proposed PartialNet framework achieved superior performance in both multi-class and binary-class AD detection.
    • Demonstrated enhanced learning capabilities through diversified depth, deep supervision, and feature reuse.
    • Outperformed state-of-the-art deep learning approaches on the benchmark ADNI dataset.

    Conclusions:

    • The developed deep learning framework offers a powerful and accurate tool for Alzheimer's disease diagnosis via MRI.
    • PartialNet's architecture provides advantages in gradient flow, parameter efficiency, and training time.
    • This approach holds significant potential for improving early and accurate detection of Alzheimer's disease.